Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma (Q36821641)

16 August 2017

Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma (English)

1 reference

16 August 2017

Matan J Cohen

1

1 reference

16 August 2017

Allan I Bloom

2

1 reference

16 August 2017

Orly Barak

3

1 reference

16 August 2017

Alexander Klimov

4

1 reference

16 August 2017

Tova Nesher

5

1 reference

16 August 2017

Daniel Shouval

6

1 reference

16 August 2017

Izhar Levi

7

1 reference

16 August 2017

Oren Shibolet

8

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

World Journal of Gastroenterology

16 August 2017

1 reference

16 August 2017

19

1 reference

16 August 2017

16

1 reference

16 August 2017

2521-2528

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Management of hepatocellular carcinoma: An update

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

A Multicenter Retrospective Study on Clinical Characteristics, Treatment Patterns, and Outcome in Elderly Patients with Hepatocellular Carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

29 September 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Hepatocellular Carcinoma in Older Adults: Clinical Features, Treatments, and Survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

The changing pattern of epidemiology in hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Prospective evaluation of the management of hepatocellular carcinoma in the elderly.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Liver transplantation in the United States, 1999-2008.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Optimal treatment strategy for elderly patients with hepatocellular carcinoma

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646143

Chemoembolization versus Chemotherapy in Elderly Patients With Unresectable Hepatocellular Carcinoma and Contrast Uptake as Prognostic Factor

20 October 2018

1 reference

12 December 2020

Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management

1 reference

12 December 2020

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly

1 reference

12 December 2020

[Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years]

1 reference

12 December 2020

Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V19.I16.2521

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23674854

1 reference